Skip to main content

Advertisement

Table 2 Significantly altered miRNAs for samples

From: MicroRNA modulation in complex regional pain syndrome

Variable p value Variable p value
hsa-miR-25# 9.29E-09 hsa-miR-20a# 0.00454
hsa-let-7c 4.33E-08 hsa-miR-16-1# 0.005137
hsa-let-7b 7.35E-08 hsa-miR-106b 0.00535
hsa-miR-320 6.06E-07 hsa-miR-532-3p 0.00535
hsa-miR-181a-2# 6.64E-05 hsa-miR-142-5p 0.005419
hsa-miR-190b 0.0006 hsa-miR-342-5p 0.005419
hsa-miR-221 0.000721 has-miR-155 0.00595
hsa-miR-629 0.002053 hsa-miR-130b 0.007069
hsa-miR-93 0.002053 hsa-miR-185 0.007069
hsa-miR-590-5p 0.002053 hsa-miR-181c 0.007069
hsa-miR-29b-2# 0.00306 hsa-miR-20b 0.007154
hsa-miR-181a 0.003087 hsa-let-7a 0.009386
hsa-miR-144# 0.003087 hsa-miR-422a 0.009471
hsa-miR-196b 0.003908 hsa-miR-340 0.009501
hsa-miR-132 0.004131 hsa-miR-324-3p 0.009501
hsa-miR-652 0.004131 hsa-miR-598 0.009975
hsa-let-7g 0.004305 hsa-let-7d 0.009975
  1. Significantly altered miRNAs for samples that clustered in Group 3, based on the miRNA profiling. The statistical significance was calculated using 2-tailed t-tests on the miRNA expression levels in patients that were in Group 3 versus other CRPS patients and control samples.